Literature DB >> 12429534

Ten year outcome in a cohort of patients with early rheumatoid arthritis: health status, disease process, and damage.

E Lindqvist1, T Saxne, P Geborek, K Eberhardt.   

Abstract

OBJECTIVE: To investigate outcome as measured by health status, disease process, and damage in an unselected group of patients with early rheumatoid arthritis (RA) monitored prospectively for 10 years and to search for prognostic factors. PATIENTS AND METHODS: 183 patients with RA with disease duration <2 years were assessed annually at a team care unit. Health status was measured by the Health Assessment Questionnaire (HAQ) and functional class. Disease process was assessed by clinical and laboratory measures of disease activity and evaluation of disease course. Damage was quantified as occurrence of major extra-articular manifestations and need for large joint replacements. Possible predictive factors were evaluated by logistic regression analyses.
RESULTS: 168/183 patients completed the entire follow up period. Of all 183 patients, 137 (75%) had been treated with disease modifying antirheumatic drugs and 84 (46%) with low dose oral glucocorticoids. After 10 years 158 patients (94%) managed daily life activities independently (functional class I-II). As measured by the HAQ 20% had almost no disability, 28% were mildly disabled, and 10% were seriously disabled. Median HAQ score had increased from 0.8 to 1.1 (p<0.001). Disease activity was significantly reduced. 133 patients (79%) had a relapsing remitting disease course and 30 patients (18%) were in remission as defined by the American College of Rheumatology criteria. Thirty patients (17%) had undergone large joint replacements. Fifteen patients (8%) had developed major extra-articular complications. The HAQ score during the first three months predicted disability at 10 years with an odds ratio of 13.4.
CONCLUSIONS: Prospective studies such as this give important knowledge of the variable long term prognosis of RA and provide necessary background information for clinical trials of new treatment modalities.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12429534      PMCID: PMC1753974          DOI: 10.1136/ard.61.12.1055

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  29 in total

1.  Preliminary criteria for clinical remission in rheumatoid arthritis.

Authors:  R S Pinals; J Baum; J Bland; W M Fosdick; S B Kaplan; A T Masi; D M Mitchell; M W Ropes; C L Short; J W Sigler; H J Weinberger
Journal:  Bull Rheum Dis       Date:  1982

2.  How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS)

Authors:  A Young; J Dixey; N Cox; P Davies; J Devlin; P Emery; S Gallivan; A Gough; D James; P Prouse; P Williams; J Winfield
Journal:  Rheumatology (Oxford)       Date:  2000-06       Impact factor: 7.580

3.  Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years.

Authors:  T Pincus; L F Callahan; W G Sale; A L Brooks; L E Payne; W K Vaughn
Journal:  Arthritis Rheum       Date:  1984-08

4.  Assessing disability in patients with rheumatoid arthritis. Use of a Swedish version of the Stanford Health Assessment Questionnaire.

Authors:  C Ekdahl; K Eberhardt; S I Andersson; B Svensson
Journal:  Scand J Rheumatol       Date:  1988       Impact factor: 3.641

Review 5.  Epidemiological aspects of studying outcome in rheumatoid arthritis.

Authors:  T D Spector
Journal:  Br J Rheumatol       Date:  1988

6.  Onset, early stages, and prognosis of rheumatoid arthritis: a clinical study of 100 patients with 11-year follow-up.

Authors:  R K Jacoby; M I Jayson; J A Cosh
Journal:  Br Med J       Date:  1973-04-14

7.  The development of disability in rheumatoid arthritis.

Authors:  Y S Sherrer; D A Bloch; D M Mitchell; D Y Young; J F Fries
Journal:  Arthritis Rheum       Date:  1986-04

8.  Complement activating rheumatoid factors in rheumatoid arthritis studied by haemolysis in gel: relation to antibody class and response to treatment with podophyllotoxin derivatives.

Authors:  L Truedsson; A G Sjöholm; G Sturfelt
Journal:  Clin Exp Rheumatol       Date:  1985 Jan-Mar       Impact factor: 4.473

9.  Remission in rheumatoid arthritis.

Authors:  F Wolfe; D J Hawley
Journal:  J Rheumatol       Date:  1985-04       Impact factor: 4.666

10.  The natural history of rheumatoid arthritis over 20 years. Clinical symptoms, radiological signs, treatment, mortality and prognostic significance of early features.

Authors:  J J Rasker; J A Cosh
Journal:  Clin Rheumatol       Date:  1987-09       Impact factor: 2.980

View more
  45 in total

Review 1.  Appropriate and effective management of rheumatoid arthritis.

Authors:  F C Breedveld; J R Kalden
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

2.  Rheumatoid Arthritis: Early diagnosis and treatment outcomes.

Authors:  Behzad Heidari
Journal:  Caspian J Intern Med       Date:  2011

Review 3.  [Early diagnosis of rheumatoid arthritis].

Authors:  M Schneider; B Ostendorf; C H Specker
Journal:  Z Rheumatol       Date:  2005-11       Impact factor: 1.372

4.  Pulmonary function test: its correlation with pulmonary high-resolution computed tomography in patients with rheumatoid arthritis.

Authors:  Daza Leonel; Cervantes Lucia; Muñiz A; Hernández Martha-Alicia; Murillo Blanca
Journal:  Rheumatol Int       Date:  2011-04-17       Impact factor: 2.631

5.  Incidence and predictors of severe extra-articular disease manifestations in an early rheumatoid arthritis inception cohort.

Authors:  C Turesson; K Eberhardt; L T H Jacobsson; E Lindqvist
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

6.  Severity of rheumatoid arthritis: the SEVERA study.

Authors:  Rafic Baddoura; Souha Haddad; Hassane Awada; Abdel Fattah Al-Masri; Georges Merheb; Said Attoui; Jad Okais; Jamil Messayke; Fadi Ghandour
Journal:  Clin Rheumatol       Date:  2005-12-15       Impact factor: 2.980

7.  Disease activity and functional changes of RA patients receiving different DMARDs in clinical practice.

Authors:  Manathip Osiri; Utis Deesomchok; Peter Tugwell
Journal:  Clin Rheumatol       Date:  2005-12-20       Impact factor: 2.980

Review 8.  Evidence for predictive validity of remission on long-term outcome in rheumatoid arthritis: a systematic review.

Authors:  Lilian H D van Tuyl; David T Felson; George Wells; Josef Smolen; Bin Zhang; Maarten Boers
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-01-15       Impact factor: 4.794

Review 9.  Efficacy, tolerability and cost effectiveness of disease-modifying antirheumatic drugs and biologic agents in rheumatoid arthritis.

Authors:  Michael T Nurmohamed; Ben A C Dijkmans
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 10.  Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs.

Authors:  Tuulikki Sokka; Minja Envalds; Theodore Pincus
Journal:  Mod Rheumatol       Date:  2008-04-25       Impact factor: 3.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.